Glenohumeral Osteoarthritis: Patient Profiles and Outcomes of Shoulder Arthroplasty

BACKGROUND AND PURPOSE: Part 1: To describe the profile of a typical patient diagnosed with glenohumeral osteoarthritis (OA) and identify predictors of total shoulder arthroplasty (TSA). Part 2: To identify outcomes after undergoing a TSA due to glenohumeral OA. METHODS: Part 1: A retrospective chart review was conducted of 127 patients with a diagnosis of glenohumeral OA from January 2011 to December 2013. Demographic data was collected. Part 2: From the original sample, a convenience sample of 22 patients was selected who were at least one year post-TSA. Consent was obtained to perform a post-surgical functional evaluation in their homes or in the clinic based on patient preference. The measures obtained were strength and range of motion (ROM), as well as the subjective reports of the Simple Shoulder Test (SST) and the Shoulder Pain and Disability Index (SPADI). RESULTS: Part 1: Of the 127 patients, average age was 70, and 55.9% were male. Surgical shoulder was the right shoulder in 52.8% of the subjects, left shoulder in 36.2% of the subjects, and bilateral shoulders in 10.2% of the subjects. The greatest predictor of undergoing a TSA was pain at rest (7.2). Part 2: There was no difference in ROM of shoulder flexion, abduction, internal rotation, and external rotation between surgical and non-surgical shoulders. Strength following a TSA was weaker in shoulder flexion and abduction, equal in rotation, and stronger in grip strength compared to the non-surgical shoulder. Average post-op pain was 1.1 compared to 6.2 pre-op pain which was statistically significant. There was a strong correlation between the SPADI and SST. CONCLUSION: The most significant indicator for a TSA is pre-op pain at rest. Patients can expect significantly decreased pain, functional ROM and strength, and improved function following a TSA. Both SPADI and SST are effective outcome measures to assess shoulder pain and function

The Second Global Workshop on Proximal Soil Sensing -Montreal 2011 4 Resistivity mapping with GEOPHILUS ELECTRICUS -information about lateral and vertical soil heterogeneity

Abstract GEOPHILUS is a novel system for mapping complex electrical bulk resistivity of soil with rolling electrodes. Amplitude and phase data are measured simultaneously for four frequencies within a range between 1 mHz and 1 kHz. The sensor design and its technical specification allow measuring the electrical parameters at five depth levels up to 1.5 m depth. Using DGPS for positioning and a suitable cross-country vehicle, it is possible to map about 100 ha/day recording 1 data point per second and 18 m line spacing

Antiepileptic drugs’ tolerability and safety – a systematic review and meta-analysis of adverse effects in dogs

<p>Various anti-epileptic drugs (AEDs) are used for the management of idiopathic epilepsy (IE) in dogs. Their safety profile is an important consideration for regulatory bodies, owners and prescribing clinicians. However, information on their adverse effects still remains limited with most of it derived from non-blinded non-randomized uncontrolled trials and case reports.</p><p><span>This poster won third place, which was presented at the Veterinary Evidence Today conference, Edinburgh November 1-3, 2016. </span></p><br /> <img src="https://www.veterinaryevidence.org/rcvskmod/icons/oa-icon.jpg" alt="Open Access" /

International Veterinary Epilepsy Task Force consensus proposal: Medical treatment of canine epilepsy in Europe

In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over the last years. Nevertheless, the same questions remain, which include, 1) when to start treatment, 2) which drug is best used initially, 3) which adjunctive AED can be advised if treatment with the initial drug is unsatisfactory, and 4) when treatment changes should be considered. In this consensus proposal, an overview is given on the aim of AED treatment, when to start long-term treatment in canine epilepsy and which veterinary AEDs are currently in use for dogs. The consensus proposal for drug treatment protocols, 1) is based on current published evidence-based literature, 2) considers the current legal framework of the cascade regulation for the prescription of veterinary drugs in Europe, and 3) reflects the authors’ experience. With this paper it is aimed to provide a consensus for the management of canine idiopathic epilepsy. Furthermore, for the management of structural epilepsy AEDs are inevitable in addition to treating the underlying cause, if possible

Predicting the abatement rates of soil organic carbon sequestration management in Western European vineyards using random forest regression

The implementation of soil organic carbon sequestration (SCS) practices on agricultural land has the potential to help to mitigate climate change at the global level. However, our understanding of the extent to which viticultural soils can contribute to this global effort remains limited. In this study, we used a random forest regression to predict the change in soil organic carbon stocks in vineyards of Western Europe under five SCS practices: organic amendments (OA), cover cropping (CC), organic amendments and no-tillage (OA+NT), no-tillage and cover cropping (NT+CC), and a combination of organic amendments, no-tillage and cover cropping (OA+NT+CC). The abatement rate of each SCS practice was modelled and mapped for six countries in Western Europe: Spain, France, Italy, Portugal, Germany and Austria. Overall, the highest abatement rate was reached under OA+NT+CC (8.29 ​Mg CO2-eq. ha−1 yr−1), whereas the lowest was observed under CC (7.03 Mg CO2-eq. ha−1 yr−1). Results showed major differences in abatement rates at the regional and national level. Despite these differences, the adoption of SCS practices was associated with a high abatement potential in the six countries and should be encouraged in the viticulture sector as a way to offset greenhouse gas emissions via soil carbon sequestration